Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: Alzheimer's Disease THErapy With NEuroaid II [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating NEuroaid II for Alzheimer's disease dementia is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEuroaid II

Snippet

Sponsor: Moleac Pte Ltd. | Conditions: Alzheimer's Disease Dementia | Phase 3 | Status: NOT_YET_RECRUITING